DIANTHUS THERAPEUTICS INC (DNTH:NASDAQ)
$106.2 2.92 (2.8273%)
Analysed DIANTHUS THERAPEUTICS INC (DNTH:NASDAQ) News Sources
Dianthus Therapeutics (DNTH) Appears Attractive Amid Solid Product Pipeline
05-06-2026
yahoo.com
Sanofi, An Argenx Rival, Bites The Dust — But A Third Biotech Took The Biggest Hit
10-06-2026
yahoo.com
Dianthus CIDP Data Lift Prospects While Funding And Dilution Risks Linger
15-06-2026
yahoo.com
Dianthus Therapeutics Announces Initiation of Phase 3 Emerge Trial of Claseprubart in Generalized Myasthenia Gravis
29-06-2026
yahoo.com
Dianthus Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(C)(4)
02-07-2026
yahoo.com
Dianthus Therapeutics Announces DNTH312, a First-In-Class, Next-Generation Bifunctional Fusion Protein Combining Claseprubart and TACI, for Severe Autoimmune Diseases
04-08-2026
yahoo.com
Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q2 2026 Financial Results
04-08-2026
yahoo.com
Dianthus Therapeutics to Participate in Three Investor Conferences During September
01-09-2026
yahoo.com
Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02-09-2026
yahoo.com
Dianthus (DNTH) Piles Up Clinical Wins While Its Losses Widen
05-09-2026
yahoo.com
What is the current price of DIANTHUS THERAPEUTICS INC (DNTH:NASDAQ)?
The current price of DIANTHUS THERAPEUTICS INC (DNTH:NASDAQ) is $106.2.
DIANTHUS THERAPEUTICS INC (DNTH:NASDAQ) absolute price change since previous trading day?
The absolute price change of DIANTHUS THERAPEUTICS INC (DNTH:NASDAQ) since the previous trading day is $2.92.
DIANTHUS THERAPEUTICS INC (DNTH:NASDAQ) percentage price change since previous trading day?
The percentage price change of DIANTHUS THERAPEUTICS INC (DNTH:NASDAQ) since the previous trading day is 2.8273%.
What is the most recent average sentiment score for DIANTHUS THERAPEUTICS INC (DNTH:NASDAQ)?
The most recent average sentiment score for DIANTHUS THERAPEUTICS INC (DNTH:NASDAQ) is 68 out of 100.
What is the most recent average sentiment for DIANTHUS THERAPEUTICS INC (DNTH:NASDAQ)?
The most recent sentiment for DIANTHUS THERAPEUTICS INC (DNTH:NASDAQ) is .
SEC-8K** Filing Available For DIANTHUS THERAPEUTICS INC (DNTH:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.